News NHS under fire for rationing hep C drugs NHS England tried to interfere with NICE appraisals, says BMJ.
News Gilead cancer drug can stay on EU market Safety experts recommend antibiotics after Zydelig treatment.
US Gilead hopes cut-price pan-genomic hep C combo will revive s... Epclusa is first treatment for all six major virus genotypes.
Articles Pharma news round-up: Pfizer-Allergan merger scrapped, Gilea... A round-up of this week's top pharma and healthcare news – plus reaction from social media. Marco Ricci reports.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
